An Alzheimer’s patient may be able to have synaptic connections restored even with plaques and tangles already in his or her brain
The first experimental drug to boost brain synapses lost in Alzheimer’s disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destructive cascade of changes in the brain that destroys the connections between neurons, leading to memory loss and cognitive decline.
The decade-long study, led by Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research, who is also a practicing clinical neurologist, shows that NitroMemantine can restore synapses, representing the connections between nerve cells (neurons) that have been lost during the progression of Alzheimer’s in the brain. The research findings are described in a paper published June 17 by the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
The focus on a downstream target to treat Alzheimer’s, rather than on amyloid beta plaques and neurofibrillary tangles—approaches which have shown little success—“is very exciting because everyone is now looking for an earlier treatment of the disease,” Lipton said. “These findings actually mean that you might be able to intercede not only early but also a bit later.” And that means that an Alzheimer’s patient may be able to have synaptic connections restored even with plaques and tangles already in his or her brain.
Targeting lost synapses
In their study, conducted in animal models as well as brain cells derived from human stem cells, Lipton and his team mapped the pathway that leads to synaptic damage in Alzheimer’s. They found that amyloid beta peptides, which were once thought to injure synapses directly, actually induce the release of excessive amounts of the neurotransmitter glutamate from brain cells called astrocytes that are located adjacent to the nerve cells.
Normal levels of glutamate promote memory and learning, but excessive levels are harmful. In patients suffering from Alzheimer’s disease, excessive glutamate activates extrasynaptic receptors, designated eNMDA receptors (NMDA stands for N-methyl-D-aspartate), which get hyperactivated and in turn lead to synaptic loss.
The Latest Bing News on:
Alzheimer’s
- An Anecdote for Alzheimer’s and Depressionon April 27, 2024 at 4:37 pm
No candles to blow out. So, in my battle against Alzheimer’s, prostate cancer, depression, internal bleeding, and a gradual shutdown of my mind and body, I look for silver linings and have turned to ...
- Unlocking Alzheimer’s: New Study Reveals Early Stage Mechanismson April 27, 2024 at 11:52 am
APP-CTFs interfere with the communication between organelles, disrupting cellular balance. Alzheimer's disease (AD) continues to be a significant and widespread neurodegenerative condition, impacting ...
- Alzheimer’s doesn’t cloud Michigan woman’s love for opera singingon April 27, 2024 at 10:00 am
She performed through the 1980s at venues like the Seattle Opera, Carnegie Hall and the Metropolitan Opera House and has a lengthy list of awards and accolades over the years.
- Neuroscientists Warn of 'Cascading' Alzheimer's Risk From These Two Habitson April 27, 2024 at 6:59 am
The habits produce a "synergistic effect" on our risk of developing Alzheimer's Disease and general cognitive decline.
- Challenging Old Theories: Innovative Microscopy Exposes New Alzheimer’s Treatment Pathwayson April 27, 2024 at 3:35 am
Researchers at UC San Diego have utilized advanced imaging techniques to explore the metabolic processes behind Alzheimer's disease, leading to potential new strategies for treatment. Alzheimer's ...
- Commentary: As Alzheimer’s risk grows, caregivers need supporton April 27, 2024 at 2:30 am
According to a new report from the Florida Chapters of the Alzheimer’s Association, an estimated one in eight people are living with Alzheimer’s. More than 840,000 are serving as their unpaid ...
- Alzheimer's All-Star Basketball Classic's founder, Gordon Thomas, inspired by dad's battle with diseaseon April 26, 2024 at 11:50 am
Celeste Taylor, Lester Quinones and Diego Maldonado are just a few of the talented players who have participated in the competitions.
- AI helps researchers uncover gut-brain interactions in Alzheimer'son April 26, 2024 at 10:00 am
AI technology reveals more information about the gut-brain health link in Alzheimer's, suggesting new pathways for research around treatments.
- Sponsored: Take on Alzheimer's campaign aims to make impact with awareness and supporton April 25, 2024 at 5:28 pm
Public Health Physician Lucia Abascal joined host Jessica Wills to share how the Take on Alzheimer's campaign is helping to spread awareness and erase stigmas surrounding the disease. Watch the clips ...
- Florida clinic plans to treat 10,000 Alzheimer’s patients a year. Look at what’s comingon April 25, 2024 at 7:20 am
Roskamp’s planned Bishop-Parker Clinic will enable Roskamp to assess, treat and support more than 10,000 patients a year, Wendy Deming, CEO of the Bishop-Parker Foundation, said Wednesday.
The Latest Google Headlines on:
Alzheimer’s
[google_news title=”” keyword=”Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Restoring synapses
- Space startup Dhruva raises ₹123cr in fundson April 24, 2024 at 4:12 pm
HDFC Bank announces Rs 60,000 crore debt raise via various instruments. Approval secured for bond renewal. Profit at Rs 16,511 crore in Jan-Mar 2023-24. Merger affects comparisons. HDFC Bank among top ...
- Halfway To Halloween: Sam Zimmerman Shares The Best Shudder Titles To Watch This Springon April 24, 2024 at 11:21 am
We all know and love the horror streaming service Shudder. From unearthing unknown gems to producing new and terrifying genre ...
- The most common Microsoft Edge problems and how to fix themon April 21, 2024 at 8:00 am
Having trouble with Microsoft Edge? You may run into issues with the maturing browser, so we provided a list of possible problems and how to fix them with ease.The Latest Tech News, Delivered to Your ...
- Cognition Therapeutics: Approaching Phase 2 Readout In Alzheimer'son April 18, 2024 at 3:56 pm
Cognition's preliminary data from the SHINE trial showed interesting results, but weren't consistent with other previous studies. See why CGTX stock is a sell.
- Molecular atlas shows how the growth factor erythropoietin affects neuronson April 18, 2024 at 6:40 am
A new study that including participants from the Central Institute of Mental Health in Mannheim shows how the growth factor erythropoietin (EPO) protects and regenerates nerve cells in the brain. In ...
- Molecular changes: How EPO affects neuronson April 18, 2024 at 1:47 am
EPO could therefore play an important role in alleviating neuropsychiatric disorders, as studies on young mice provide information on how EPO can help to repair and maintain transcriptional networks ...
- US FDA clears Spinogenix’s IND application for SPG601 to treat people with Fragile X Syndromeon April 17, 2024 at 4:30 am
US FDA clears Spinogenix’s IND application for SPG601 to treat people with Fragile X Syndrome: San Diego Wednesday, April 17, 2024, 17:00 Hrs [IST] Spinogenix, Inc., a clinical- ...
- FDA Clears Spinogenix's Phase 2a Trial for Innovative Fragile X Syndrome Treatmenton April 15, 2024 at 1:35 pm
Spinogenix, announced that the FDA has approved their Investigational New Drug application for SPG601, a novel treatment aimed at individuals with Fragile X Syndrome.
- Spinogenix Announces U.S. FDA Approval of its Investigational New Drug Application for its Phase 2a Clinical Trial of SPG601 for Fragile X Syndromeon April 15, 2024 at 5:00 am
SPG601 is a once-a-day pill that works by restoring synaptic function to address core symptoms of Fragile X SyndromeSAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage ...
- Over the Span of AD, Roles of Astrocytes and Microglia Changeon April 11, 2024 at 5:00 pm
Bellaver speculates that astrocytes change when they sense amyloid buildup in the brain. “They get reactive and progressively lose neuroprotective functions and/or gain novel neurotoxic properties, ...
The Latest Google Headlines on:
Restoring synapses
[google_news title=”” keyword=”restoring synapses” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]